MarketScreener Homepage > Equities > Xetra > Fresenius SE & Co. KGaA FRE DE0005785604

Report

Delayed Xetra - 03/05 11:35:00 am
36.03	EUR		+0.17%

03/05

PRESS RELEASE : Nanogate SE: Divestment of Nanogate Medical Systems GmbH

03/01

DGAP-DD : Fresenius Medical Care AG & Co. KGaA english

03/01

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg

Summary

Quotes 5-day view Delayed Quote.

Delayed Xetra

03/01/2021	03/02/2021	03/03/2021	03/04/2021	03/05/2021	Date
35.93(c)	35.84(c)	35.5(c)	35.97(c)	36.03(c)	Last
1 526 596	1 668 416	1 402 094	1 489 104	1 451 463	Volume
+1.38%	-0.25%	-0.95%	+1.32%	+0.17%	Change

More quotes

Financials

Sales 2020	36 158 M 43 067 M 43 067 M
Net income 2020	1 735 M 2 067 M 2 067 M
Net Debt 2020	23 519 M 28 014 M 28 014 M
P/E ratio 2020	11,4x
Yield 2020	2,23%

Sales 2021	36 834 M 43 873 M 43 873 M
Net income 2021	1 768 M 2 106 M 2 106 M
Net Debt 2021	21 660 M 25 800 M 25 800 M
P/E ratio 2021	11,4x
Yield 2021	2,35%

Capitalization	20 088 M 23 932 M 23 927 M
EV / Sales 2020	1,21x
EV / Sales 2021	1,13x
Nbr of Employees	311 269
Free-Float	72,0%

More Financials

Company

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (49.2%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (31.4%;...

Sector

Healthcare Facilities & Services

Calendar

05/06

Earnings Release

More about the company

Notations Surperformance© of Fresenius SE & Co. KGaA

Trading Rating :

Investor Rating :

More Ratings

All news about FRESENIUS SE & CO. KGAA

03/05	PRESS RELEASE : Nanogate SE: Divestment of Nanogate Medical Systems GmbH	DJ
03/01	DGAP-DD : Fresenius Medical Care AG & Co. KGaA english	DJ
03/01	FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Berenberg	MD
02/26	PRESS RELEASE : Nanogate SE: Divestment of Nanogate Kierspe GmbH	DJ
02/26	FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Goldman Sachs	MD
02/26	FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from JP Morgan	MD
02/26	FRESENIUS SE : JP Morgan gives a Buy rating	MD
02/25	FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..	EQ
02/25	FMC FRESENIUS MEDICAL CARE AG & CO K : Independant Research reiterates its Buy r..	MD
02/25	DGAP-DD : Fresenius SE & Co. KGaA english	DJ
02/25	DGAP-DD : Fresenius Medical Care AG & Co. KGaA english	DJ
02/24	FRESENIUS : wins tenth consecutive Potentialpark award for Germany's best onlin..	PU
02/24	FRESENIUS SE : NorldLB keeps its Buy rating	MD
02/24	FRESENIUS MEDICAL CARE : RBC Adjusts Price Target on Fresenius Medical Care to ..	MT
02/24	FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reiterates its Neutral rati..	MD

More news

News in other languages on FRESENIUS SE & CO. KGAA

03/05	DGAP-NEWS : Nanogate SE veräußert Nanogate Medical Systems GmbH
03/05	OLIVER BÄTE : Allianz-Chef Bäte bekommt zwölf Prozent Gehaltserhöhung
03/05	CONTINENTAL IM FOKUS : Neuer Chef muss zahlreiche Probleme lösen
03/05	Weniger Covid-19-Patienten - aber nicht mehr freie Intensivbetten
03/04	DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 04.03.2021 - 15.15 Uhr

More news

Analyst Recommendations on FRESENIUS SE & CO. KGAA

03/01	FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Berenberg	MD
02/26	FMC FRESENIUS MEDICAL CARE AG & CO K : Buy rating from Goldman Sachs	MD
02/26	FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from JP Morgan	MD

More recommendations

Provided by Scoopnest.com

Analysis

Italy looks to safeguard biomedical valley leading fight against COVID-19

More Must read

Chart FRESENIUS SE & CO. KGAA

Duration : Period :

Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends FRESENIUS SE & CO. KGAA

	Short Term	Mid-Term	Long Term
Trends	Bearish	Neutral	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	21
Average target price	45,55 €
Last Close Price	36,03 €
Spread / Highest target	88,7%
Spread / Average Target	26,4%
Spread / Lowest Target	-51,0%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Stephan Sturm	President & Chief Executive Officer
Rachel Clare Empey	Chief Financial Officer
Gerd Krick	Chairman-Supervisory Board
Jürgen Götz	Chief Legal & Compliance Officer
Niko Stumpfögger	Deputy Chairman-Supervisory Board

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

FRESENIUS SE & CO. KGAA	-4.78%	23 932



AIER EYE HOSPITAL GROUP CO., LTD.	-16.14%	39 848
TOPCHOICE MEDICAL CORPORATION	-14.17%	11 716
IHH HEALTHCARE	-3.09%	11 447
RAMSAY HEALTH CARE LIMITED	3.30%	11 195
BANGKOK DUSIT MEDICAL SERVICES	3.37%	11 180

More Results